Biotech Values

[vinmantoo]

The amount of time for the RSV trials has been difficult to reconcile, and I am not totally convinced of the list of performance sites as far as I wondered if some were the best suited and I wondered why others were not utilized.

Precautions taken during the pandemic essentially eliminated 2 years of the RSV season, which explains the delay.

As far as the EDP-235 trial, it showed that this drug is safe and effective at reducing symptoms, both of which are the metrics for FDA approval. What the general public does now with regards to ENTA price is irrelevant to its prospects. As Warren Buffett once said, the stock market is voting machine in the short term and a weighing machine in the long term.